US Stock MarketDetailed Quotes

SONN Sonnet BioTherapeutic

Watchlist
  • 1.5900
  • +0.0500+3.25%
Close Feb 14 16:00 ET
  • 1.5997
  • +0.0097+0.61%
Post 20:01 ET
4.87MMarket Cap-0.15P/E (TTM)

Sonnet BioTherapeutic Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q1)Dec 31, 2024
(FY)Sep 30, 2024
(Q4)Sep 30, 2024
(Q3)Jun 30, 2024
(Q2)Mar 31, 2024
(Q1)Dec 31, 2023
(FY)Sep 30, 2023
(Q4)Sep 30, 2023
(Q3)Jun 30, 2023
(Q2)Mar 31, 2023
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
5.87%-2.91M
59.67%-8.61M
30.47%-3.17M
50.27%-3.07M
115.41%723.79K
47.73%-3.09M
23.16%-21.34M
27.03%-4.56M
21.12%-6.17M
16.28%-4.7M
Net income from continuing operations
-170.49%-3.16M
60.51%-7.44M
14.91%-3.13M
11.18%-3.51M
106.45%365.43K
78.92%-1.17M
36.64%-18.83M
50.55%-3.68M
49.90%-3.95M
30.96%-5.67M
Depreciation and amortization
11.11%22.19K
9.72%83.12K
10.99%21.61K
10.87%21.04K
8.60%20.5K
8.35%19.97K
-18.77%75.75K
8.58%19.47K
-19.91%18.98K
-27.93%18.87K
Other non cash items
0.00%12K
36.23%384.16K
--12K
--360.16K
--0
-88.00%12K
-70.97%282K
----
----
-92.75%12K
Change In working capital
107.77%155.87K
40.01%-1.87M
87.02%-123.58K
99.28%-17.65K
-68.60%277.48K
-243.90%-2.01M
-43,305.16%-3.12M
-196.70%-951.85K
-270.29%-2.46M
-57.05%883.67K
-Change in receivables
-83.92%95.29K
135.36%24.5K
-548.22%-242.47K
53.12%-141.65K
-120.67%-183.85K
195.69%592.46K
90.34%-69.27K
94.79%-37.41K
---302.16K
--889.41K
-Change in prepaid assets
-96.45%9.54K
1,499.54%470.99K
-182.35%-152.58K
100.77%5.01K
-0.85%349.44K
225.52%269.12K
92.59%-33.65K
-38.36%185.29K
1.53%-654.04K
432.15%352.43K
-Change in payables and accrued expense
92.37%-210.14K
8.60%-2.19M
137.67%296.46K
110.88%141.39K
138.25%122.61K
-35,299.17%-2.75M
-248.80%-2.4M
-153.15%-786.91K
-1,680.12%-1.3M
-114.05%-320.55K
-Change in other current assets
461.97%281.09K
80.70%-79.94K
97.81%-5.67K
97.66%-3.64K
--7.02K
---77.66K
---414.21K
---258.84K
---155.37K
--0
-Change in other current liabilities
-15.57%-19.91K
-42.31%-73.05K
-15.56%-19.32K
-15.56%-18.75K
-1,403.98%-17.75K
-0.14%-17.23K
38.66%-51.33K
-0.16%-16.72K
24.39%-16.23K
94.93%-1.18K
-Change in other working capital
----
87.40%-18.63K
--0
--0
--0
50.00%-18.63K
57.76%-147.81K
40.63%-37.26K
40.63%-36.85K
61.77%-36.45K
Cash from discontinued investing activities
Operating cash flow
5.87%-2.91M
59.67%-8.61M
30.47%-3.17M
50.27%-3.07M
115.41%723.79K
47.73%-3.09M
23.16%-21.34M
27.03%-4.56M
21.12%-6.17M
16.28%-4.7M
Investing cash flow
Cash flow from continuing investing activities
97.29%-12K
0
0.00%-12K
45.29%-443.25K
-375.75%-170K
97.95%-12K
Net intangibles purchase and sale
----
97.29%-12K
--0
0.00%-12K
----
----
45.29%-443.25K
-375.75%-170K
97.95%-12K
----
Cash from discontinued investing activities
Investing cash flow
----
97.29%-12K
--0
0.00%-12K
----
----
45.29%-443.25K
-375.75%-170K
97.95%-12K
----
Financing cash flow
Cash flow from continuing financing activities
98.56%7.62M
-69.08%6.49M
-1,226.09%-234.71K
57.02%2.85M
-99.72%41K
-15.87%3.84M
423.26%21.01M
-100.44%-17.7K
1.81M
14.65M
Net issuance payments of debt
----
--0
--0
----
----
----
---748
--0
----
----
Net common stock issuance
100.87%7.71M
-81.45%3.9M
85.42%-2.58K
-96.68%60.29K
--0
-15.87%3.84M
1,040.46%21.01M
-100.96%-17.7K
--1.81M
--14.65M
Proceeds from stock option exercised by employees
---13.87K
351,345.11%2.98M
---19.2K
347,010.48%2.95M
--56K
--0
--849
--0
--849
----
Net other financing activities
---75K
---385.43K
---212.93K
---157.5K
----
----
----
----
----
----
Cash from discontinued financing activities
Financing cash flow
98.56%7.62M
-69.08%6.49M
-1,226.09%-234.71K
57.02%2.85M
-99.72%41K
-15.87%3.84M
423.26%21.01M
-100.44%-17.7K
--1.81M
--14.65M
Net cash flow
Beginning cash position
-93.43%149.46K
-25.50%2.27M
-49.38%3.55M
-66.76%3.79M
77.67%3.02M
-25.50%2.27M
-88.95%3.05M
34.38%7.02M
-16.47%11.39M
-91.24%1.7M
Current changes in cash
530.68%4.71M
-172.89%-2.12M
28.27%-3.4M
94.69%-231.85K
-92.11%764.79K
155.25%747.13K
96.83%-778.62K
-118.57%-4.75M
48.05%-4.37M
267.81%9.69M
End cash Position
60.90%4.86M
-93.43%149.46K
-93.43%149.46K
-49.38%3.55M
-66.76%3.79M
77.67%3.02M
-25.50%2.27M
-25.50%2.27M
34.38%7.02M
-16.47%11.39M
Free cash flow
5.87%-2.91M
60.43%-8.62M
32.96%-3.17M
50.17%-3.08M
114.60%723.79K
47.73%-3.09M
23.79%-21.79M
23.55%-4.73M
26.48%-6.18M
14.16%-4.96M
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
Unqualified Opinion with Explanatory Notes
--
--
--
--
Unqualified Opinion with Explanatory Notes
--
--
--
(Q1)Dec 31, 2024(FY)Sep 30, 2024(Q4)Sep 30, 2024(Q3)Jun 30, 2024(Q2)Mar 31, 2024(Q1)Dec 31, 2023(FY)Sep 30, 2023(Q4)Sep 30, 2023(Q3)Jun 30, 2023(Q2)Mar 31, 2023
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities 5.87%-2.91M59.67%-8.61M30.47%-3.17M50.27%-3.07M115.41%723.79K47.73%-3.09M23.16%-21.34M27.03%-4.56M21.12%-6.17M16.28%-4.7M
Net income from continuing operations -170.49%-3.16M60.51%-7.44M14.91%-3.13M11.18%-3.51M106.45%365.43K78.92%-1.17M36.64%-18.83M50.55%-3.68M49.90%-3.95M30.96%-5.67M
Depreciation and amortization 11.11%22.19K9.72%83.12K10.99%21.61K10.87%21.04K8.60%20.5K8.35%19.97K-18.77%75.75K8.58%19.47K-19.91%18.98K-27.93%18.87K
Other non cash items 0.00%12K36.23%384.16K--12K--360.16K--0-88.00%12K-70.97%282K---------92.75%12K
Change In working capital 107.77%155.87K40.01%-1.87M87.02%-123.58K99.28%-17.65K-68.60%277.48K-243.90%-2.01M-43,305.16%-3.12M-196.70%-951.85K-270.29%-2.46M-57.05%883.67K
-Change in receivables -83.92%95.29K135.36%24.5K-548.22%-242.47K53.12%-141.65K-120.67%-183.85K195.69%592.46K90.34%-69.27K94.79%-37.41K---302.16K--889.41K
-Change in prepaid assets -96.45%9.54K1,499.54%470.99K-182.35%-152.58K100.77%5.01K-0.85%349.44K225.52%269.12K92.59%-33.65K-38.36%185.29K1.53%-654.04K432.15%352.43K
-Change in payables and accrued expense 92.37%-210.14K8.60%-2.19M137.67%296.46K110.88%141.39K138.25%122.61K-35,299.17%-2.75M-248.80%-2.4M-153.15%-786.91K-1,680.12%-1.3M-114.05%-320.55K
-Change in other current assets 461.97%281.09K80.70%-79.94K97.81%-5.67K97.66%-3.64K--7.02K---77.66K---414.21K---258.84K---155.37K--0
-Change in other current liabilities -15.57%-19.91K-42.31%-73.05K-15.56%-19.32K-15.56%-18.75K-1,403.98%-17.75K-0.14%-17.23K38.66%-51.33K-0.16%-16.72K24.39%-16.23K94.93%-1.18K
-Change in other working capital ----87.40%-18.63K--0--0--050.00%-18.63K57.76%-147.81K40.63%-37.26K40.63%-36.85K61.77%-36.45K
Cash from discontinued investing activities
Operating cash flow 5.87%-2.91M59.67%-8.61M30.47%-3.17M50.27%-3.07M115.41%723.79K47.73%-3.09M23.16%-21.34M27.03%-4.56M21.12%-6.17M16.28%-4.7M
Investing cash flow
Cash flow from continuing investing activities 97.29%-12K00.00%-12K45.29%-443.25K-375.75%-170K97.95%-12K
Net intangibles purchase and sale ----97.29%-12K--00.00%-12K--------45.29%-443.25K-375.75%-170K97.95%-12K----
Cash from discontinued investing activities
Investing cash flow ----97.29%-12K--00.00%-12K--------45.29%-443.25K-375.75%-170K97.95%-12K----
Financing cash flow
Cash flow from continuing financing activities 98.56%7.62M-69.08%6.49M-1,226.09%-234.71K57.02%2.85M-99.72%41K-15.87%3.84M423.26%21.01M-100.44%-17.7K1.81M14.65M
Net issuance payments of debt ------0--0---------------748--0--------
Net common stock issuance 100.87%7.71M-81.45%3.9M85.42%-2.58K-96.68%60.29K--0-15.87%3.84M1,040.46%21.01M-100.96%-17.7K--1.81M--14.65M
Proceeds from stock option exercised by employees ---13.87K351,345.11%2.98M---19.2K347,010.48%2.95M--56K--0--849--0--849----
Net other financing activities ---75K---385.43K---212.93K---157.5K------------------------
Cash from discontinued financing activities
Financing cash flow 98.56%7.62M-69.08%6.49M-1,226.09%-234.71K57.02%2.85M-99.72%41K-15.87%3.84M423.26%21.01M-100.44%-17.7K--1.81M--14.65M
Net cash flow
Beginning cash position -93.43%149.46K-25.50%2.27M-49.38%3.55M-66.76%3.79M77.67%3.02M-25.50%2.27M-88.95%3.05M34.38%7.02M-16.47%11.39M-91.24%1.7M
Current changes in cash 530.68%4.71M-172.89%-2.12M28.27%-3.4M94.69%-231.85K-92.11%764.79K155.25%747.13K96.83%-778.62K-118.57%-4.75M48.05%-4.37M267.81%9.69M
End cash Position 60.90%4.86M-93.43%149.46K-93.43%149.46K-49.38%3.55M-66.76%3.79M77.67%3.02M-25.50%2.27M-25.50%2.27M34.38%7.02M-16.47%11.39M
Free cash flow 5.87%-2.91M60.43%-8.62M32.96%-3.17M50.17%-3.08M114.60%723.79K47.73%-3.09M23.79%-21.79M23.55%-4.73M26.48%-6.18M14.16%-4.96M
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions --Unqualified Opinion with Explanatory Notes--------Unqualified Opinion with Explanatory Notes------
Trending Stocks
Best Growth Stocks Best Growth Stocks

Spot stocks with huge growth potential and solid financial standing. Spot stocks with huge growth potential and solid financial standing.

Symbol Mini Chart % Chg
DOMINOS PIZZA ENTERPRISES LIMITED UNSP ADR EACH REPR 0.5 ORD SHS
DMZPY
+17.56%
DexCom
DXCM
+5.92%
Hutchmed (China)
HCM
+4.39%
New Fortress Energy
NFE
+2.70%
Enerpac Tool
EPAC
+1.85%

Unlock the Full List